Login
← Go Back
Shilpa Medicare
SHILPAMED · Pharma > Pharmaceuticals & Drugs · Chairman: Omprakash Inani · MD: Vishnukant Bhutada · Listing date: Dec. 4, 2009 · Employees: 2350 · Raichur · http://www.vbshilpa.com
Stock Price vs Company Growth
1d
3.4%
1w
2.5%
1m
20.1%
3m
82.1%
6m
76.3%
1y
23.0%
5y
17.4%
10y
9.5%
all
19.2%
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 573 3.4%
312
581
Company Overview
Sales
1,538 Cr
Growth: 15.2%
Profit after Tax
218 Cr
Growth: 45.5%
Mid Cap
11,204 Cr
P/E: 50.3x
Industry P/E: 31.3x
Fundamentals
Sales (Cr) ₹ 1,538
Growth 15.2%
EBITDA 28.2%
P/S 7.3x
Dividend 0.1%
P/E 50.3x
Book Value ₹ 132
PEG Ratio 3.3x
ROE 8.7%
P/B 4.3x
Shareholding Pattern
Institutions
Ta Fii Investors Fund
3.71 %
Tano Mauritius India Fvci Ii
2.43 %
Pivotal Enterprises Private Limited
2.35 %
Pivotal Business Managers Llp
1.75 %
Duro One Investments Limited
1.42 %
Promoters
Vishnukant Chaturbhuj Bhutada
7.81 %
Dharmavati Bhutada
7.61 %
Ravi Kumar Innani
4.91 %
Suraj Kumar Innani
4.88 %
Ramakant Innani
4.29 %
Others
Increase    Decrease    No change
Company Profile Detailed
Shilpa Medicare, established in 1987, has carved a niche for itself in the exceedingly competitive and quality-conscious sphere of pharmaceuticals manufacturing. It produces and exports consistently high-quality Active Pharmaceutical Ingredients Fine Chemicals, intermediates, herbal products and speciality chemical products using sophisticated technology, meticulously following international specifications.
Belongs to (12 Indices) view more
Investors (148)
cohesion...
vishnuka...
ubs.ag
Followers (8)
nitin2
keerthi
deepak